Pluvicto (lutetium Lu 177 vipivotide tetraxetan) - Novartis
Lynparza (olaparib) - Merck (MSD), AstraZeneca
https://www.sciencedirect.com/science/article/pii/S3051291326002855?via%3Dihub
 
Q. Wu 1, 2; L. Luo 3; R. P. Baum 4; J. Zhang 1, 2, 5
 
Sep 29, 2026
 
Prev Next